Target intelligence / Profile preview

Keratin aggregates in hyperkeratotic stratum corneum

Molecular classification
Intermediate filament protein, Structural protein, Other
01

Overview

Keratin aggregates in the hyperkeratotic stratum corneum represent a pathological accumulation of keratinized cells and proteins, leading to a thickened and often dysfunctional skin barrier. In healthy skin, keratinocytes undergo a programmed process of differentiation and desquamation; however, in hyperkeratotic conditions, this balance is disrupted, resulting in the formation of dense, hard keratin structures. These aggregates are a hallmark of various dermatological disorders, including psoriasis, ichthyosis, and common calluses. Therapeutic intervention typically involves the use of keratolytic agents, which work by breaking down the protein bonds within the keratin matrix or by increasing the hydration of the stratum corneum to facilitate shedding. By targeting these aggregates, treatments aim to restore normal skin texture, improve barrier function, and alleviate symptoms such as scaling and itching. Understanding the composition and physical properties of these aggregates is crucial for developing effective topical formulations that can penetrate the thickened epidermis.

Other names
Hyperkeratotic keratinKeratinous debrisCorneocyte aggregatesKeratinized scales
02

Mechanism of action

Keratolytic agents act by disrupting the intercellular bonds (desmosomes) between corneocytes or by denaturing and hydrating the keratin protein matrix, which facilitates the softening and shedding of the thickened stratum corneum.

03

Biological functions

Structural integrity of the skinBarrier functionProtection against mechanical stressDesquamation
04

Disease associations

PsoriasisIchthyosisKeratosis pilarisActinic keratosisCallusWarts
05

Safety considerations

Skin irritationErythemaChemical burnsSystemic toxicity (e.g., salicylism from extensive topical use)Increased photosensitivity
06

Interacting drugs

Salicylic acid

6 more in the full profile.

07

Biomarkers

Stratum corneum thicknessKeratin 1 expressionKeratin 10 expressionTransepidermal water loss (TEWL)

Beyond the preview

Go deeper on Keratin aggregates in hyperkeratotic stratum corneum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin aggregates in hyperkeratotic stratum corneum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call